Wow point 2 is something that I’m still attempting to process. Having treated about 7 years ago with the older chemicals this is a concept I struggle to comprehend. ‘Some being detectable at the end of treatment but go on to svr’. Obviously this research has been developed from the more recent DAA research, can you point us in the direction of this data? Em
Point 2 has been a question in my mind for some time. I am glad to get a definitive answer on it, thanks. As you say, things are moving very fast in the hepc world. I seem to find out new info daily, and lately from this website which is turning out to be a very valuable source.
The information on end of treatment “detectable” HCV RNA and SVR was contained in presentations at EASL Conference in April, so not yet fully published.